Skip to main content

Marex Group plc

Position in PFE — Pfizer Inc

CIK 1997464 London, X0

Position in PFE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,310,079
-$2,571,430 QoQ
Shares Held
178,990
-27.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#650
of 2,821 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Jun 30, 2026
CallValue
$1,926,400
CallShares
80,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Marex Group plc holds $405,541,812 across 9 Drug Manufacturers - General names. PFE ranks #4 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 PFE
Pfizer Inc
This page
178,990 $4,310,079

All Filings in PFE

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,926,400 80,000
2026-06-30 $4,310,079 178,990
2026-03-31 $6,881,509 245,068
2026-03-31 $2,246,400 80,000
2025-12-31 $5,367,990 215,582
2025-12-31 $5,602,500 225,000
2025-09-30 $1,355,255 53,189
2025-09-30 $5,733,000 225,000
2025-06-30 $1,586,774 65,461
2025-03-31 $1,790,853 70,673
2024-12-31 $2,767,927 104,332
2024-09-30 $2,773,493 95,836
2023-12-31 $1,141,925 39,664